Sartorius Aktiengesellschaft (SOAGY)

OTCMKTS · Delayed Price · Currency is USD
52.77
-0.09 (-0.17%)
Feb 14, 2025, 4:00 PM EST
-29.35%
Market Cap 16.03B
Revenue (ttm) 3.50B
Net Income (ttm) 86.97M
Shares Out n/a
EPS (ttm) 1.26
PE Ratio 184.29
Forward PE n/a
Dividend 0.09 (0.16%)
Ex-Dividend Date Mar 31, 2025
Volume 2,000
Average Volume 4,863
Open 52.01
Previous Close 52.86
Day's Range 51.62 - 52.83
52-Week Range 42.32 - 83.59
Beta 1.04
RSI 49.96
Earnings Date Apr 16, 2025

About SOAGY

Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services in the United States and internationally. The company offers multi-parallel, benchtop, single-use, stainless steel, cell culture, rocking motion, and microbial bioreactors, and software apps for bioreactors and cell culture shake flask; fermenters; cell culture media products; cellcelector flex, incubator flowbox, nanowell arrays, and capillaries and tips; fluid management products; microbiology products; and Ultrafiltration membrane filters, glass and quar... [Read more]

Sector Healthcare
Founded 1870
Employees 13,528
Stock Exchange OTCMKTS
Ticker Symbol SOAGY
Full Company Profile

Financial Performance

In 2024, SOAGY's revenue was 3.38 billion, a decrease of -0.44% compared to the previous year's 3.40 billion. Earnings were 84.00 million, a decrease of -59.14%.

Financial numbers in EUR Financial Statements

News

Sartorius lifts U.S. peers after 2024 results

Sartorius (SARTF) jumps as the company projects a positive outlook with its 2024 results sending its U.S. peers, Repligen (RGEN) and Bio-Rad (BIO) higher. Read more here.

4 weeks ago - Seeking Alpha

Sartorius Aktiengesellschaft Non-GAAP EPS of €4.05, revenue of €3.38B; initiates FY25 soft outlook

Sartorius Aktiengesellschaft press release (SARTF): FY Non-GAAP EPS of €4.05. Revenue of €3.38B (-0.3% Y/Y). Order intake + 10.8 percent, demand increasingly picking

4 weeks ago - Seeking Alpha

ESG Roundup: Market Talk

Gain insight on Macy’s response to activist investors, Sartorius’s new CEO and more in the latest Market Talks covering ESG Impact Investing.

2 months ago - The Wall Street Journal

Betting on Growth: 4 Favorite Stocks From T. Rowe Price's Peter Bates

The manager of the Global Select Equity Strategy looks for high margins, cash generation, competitive advantages, and a long runway of growth.

4 months ago - Barrons

'We are in a year of transition,' says Sartorius CEO

Sartorius CEO Joachim Kreuzburg discusses the pharmaceutical industry and his business outlook.

5 months ago - CNBC

Sartorius Aktiengesellschaft (SARTF) Q1 2024 Earnings Call Transcript

Sartorius Aktiengesellschaft (OTCPK:SARTF) Q1 2024 Earnings Conference Call April 18, 2024 7:00 AM ET Corporate Participants Dr. Joachim Kreuzburg - Chairman René Fáber - Chief Executive Officer Flori...

11 months ago - Seeking Alpha

Sartorius Aktiengesellschaft (SARTF) Q4 2023 Earnings Call Transcript

Sartorius Aktiengesellschaft (SARTF) Q4 2023 Earnings Call Transcript

1 year ago - Seeking Alpha

10 stocks for investors looking for ‘wonderful companies at a fair price'

As money managers talk about various methods of selecting quality companies, investors might also think about diversification, which can lower risk and broaden opportunities.

1 year ago - Market Watch

These 5 DAX index companies are in trouble as their stocks plunge

German stocks are not doing well as the economy goes through substantial challenges. The most recent data showed that business confidence has tumbled while manufacturing and services PMIs have remaine...

1 year ago - Invezz

Sartorius Aktiengesellschaft (SARTF) Q2 2023 Earnings Call Transcript

Sartorius Aktiengesellschaft (OTCPK:SARTF) Q2 2023 Earnings Conference Call July 21, 2023 9:30 AM ET Company Participants Joachim Kreuzburg - Chairman of the Executive Board and Chief Executive Office...

1 year ago - Seeking Alpha

Sartorius: A German Champion With A Discounted Price

Sartorius has been experiencing a demand decline since 2022. Sartorius serves a niche market, which gives it a strong moat. Sartorius benefits from the long-term tailwinds of its sector.

1 year ago - Seeking Alpha

Sartorius Aktiengesellschaft (SARTF) Q1 2023 Earnings Call Transcript

Sartorius Aktiengesellschaft (SARTF) Q1 2023 Earnings Call Transcript.

2 years ago - Seeking Alpha

Sartorius, Sartorius Stedim shares fall after Polyplus acquisition

Shares in German pharmaceutical and laboratory equipment supplier Sartorius AG and its France-listed subsidiary Sartorius Stedim Biotech SA DIM, -6.51% fell in opening trade on Friday after the compan...

2 years ago - Market Watch

Sartorius AG: Combating And Benefiting From Eroom's Law

Sartorius is a low volume, almost private business, but offers investors exposure to great fundamentals in healthcare. With qualities that separate them from larger peers, Sartorius may offer a better...

2 years ago - Seeking Alpha

Sartorius Aktiengesellschaft (SARTF) Q4 2022 Earnings Call Transcript

Sartorius Aktiengesellschaft (OTCPK:SARTF) Q4 2022 Earnings Conference Call January 26, 2023 9:30 AM ET Company Participants Joachim Kreuzburg - Chairman of Exec. Board & CEO Rainer Lehmann - CFO, Mem...

2 years ago - Seeking Alpha

Sartorius Aktiengesellschaft (SARTF) Q3 2022 Earnings Call Transcript

Sartorius Aktiengesellschaft (OTCPK:SARTF) Q3 2022 Earnings Conference Call October 19, 2022 9:30 AM ET Corporate Participants Joachim Kreuzburg - Chief Executive Officer Rainer Lehmann - Chief Financ...

2 years ago - Seeking Alpha

Sartorius Aktiengesellschaft (SARTF) CEO Joachim Kreuzburg on Q2 2022 Results - Earnings Call Transcript

Sartorius Aktiengesellschaft (OTCPK:SARTF) Q2 2022 Earnings Conference Call July 21, 2022 9:30 AM ET Company Participants Joachim Kreuzburg - Chief Executive Officer Rainer Lehmann - Chief Financial O...

2 years ago - Seeking Alpha

Sartorius AG: Buy The French Subsidiary Instead

Sartorius AG and Sartorius Stedim are a buy after a significant drawdown. Sartorius is operating in the fast-growing biopharmaceutical industry.

3 years ago - Seeking Alpha

Sartorius AG (SARTF) CEO Joachim Kreuzburg on Q1 2022 Results - Earnings Call Transcript

Sartorius AG ( OTCPK:SARTF) Q1 2022 Results Conference Call April 21, 2022 9:30 AM ET Company Participants Joachim Kreuzburg - CEO Rainer Lehmann - CFO Conference Call Participants Delphine Le Louet ...

3 years ago - Seeking Alpha

Sartorius Aktiengesellschaft (SARTF) CEO Joachim Kreuzburg on Q4 2021 Results - Earnings Call Transcript

Sartorius Aktiengesellschaft (SARTF) CEO Joachim Kreuzburg on Q4 2021 Results - Earnings Call Transcript

3 years ago - Seeking Alpha

Sartorius Aktiengesellschaft (SARTF) CEO Joachim Kreuzburg on Q3 2021 Results - Earnings Call Transcript

Sartorius Aktiengesellschaft (SARTF) CEO Joachim Kreuzburg on Q3 2021 Results - Earnings Call Transcript

3 years ago - Seeking Alpha